127 related articles for article (PubMed ID: 3009066)
1. High dose chemotherapy in solid tumours in adults.
Souhami R; Peters W
Clin Haematol; 1986 Feb; 15(1):219-34. PubMed ID: 3009066
[TBL] [Abstract][Full Text] [Related]
2. [High-doses chemotherapy followed by bone marrow autograft in the treatment of small cell bronchial cancer].
Pico JL; Baume D; Ostronoff M; Beaujean F; Gouyette A; Le Chevalier T; Arriagada R; Rebattu P; Hayat M
Bull Cancer; 1987; 74(5):587-95. PubMed ID: 2825862
[TBL] [Abstract][Full Text] [Related]
3. Overview of the clinical relevance of autologous bone marrow transplantation.
Appelbaum FR; Buckner CD
Clin Haematol; 1986 Feb; 15(1):1-18. PubMed ID: 3516484
[No Abstract] [Full Text] [Related]
4. Perspectives for the use of high-dose chemotherapy in the treatment of solid malignant tumors.
Sculier JP; Klastersky J
Eur J Cancer Clin Oncol; 1984 Nov; 20(11):1335-7. PubMed ID: 6389145
[No Abstract] [Full Text] [Related]
5. High-dose thiotepa alone and in combination regimens with bone marrow support.
Antman K; Eder JP; Elias A; Ayash L; Shea TC; Weissman L; Critchlow J; Schryber SM; Begg C; Teicher BA
Semin Oncol; 1990 Feb; 17(1 Suppl 3):33-8. PubMed ID: 2106166
[TBL] [Abstract][Full Text] [Related]
6. Etoposide with lonidamine or pentoxifylline as modulators of alkylating agent activity in vivo.
Tanaka J; Teicher BA; Herman TS; Holden SA; Dezube B; Frei E
Int J Cancer; 1991 Jun; 48(4):631-7. PubMed ID: 2045206
[TBL] [Abstract][Full Text] [Related]
7. High-dose combination cyclophosphamide, cisplatin, and melphalan with autologous bone marrow support. A clinical and pharmacologic study.
Peters WP; Stuart A; Klotman M; Gilbert C; Jones RB; Shpall EJ; Gockerman J; Bast RC; Moore JO
Cancer Chemother Pharmacol; 1989; 23(6):377-83. PubMed ID: 2653660
[TBL] [Abstract][Full Text] [Related]
8. Cisplatin and etoposide regimen is superior to cyclophosphamide, epirubicin, and vincristine regimen in small-cell lung cancer: results from a randomized phase III trial with 5 years' follow-up.
Sundstrøm S; Bremnes RM; Kaasa S; Aasebø U; Hatlevoll R; Dahle R; Boye N; Wang M; Vigander T; Vilsvik J; Skovlund E; Hannisdal E; Aamdal S;
J Clin Oncol; 2002 Dec; 20(24):4665-72. PubMed ID: 12488411
[TBL] [Abstract][Full Text] [Related]
9. High-dose combination alkylating agent preparative regimen with autologous bone marrow support: the Dana-Farber Cancer Institute/Beth Israel Hospital experience.
Antman K; Eder JP; Elias A; Shea T; Peters WP; Andersen J; Schryber S; Henner WD; Finberg R; Wilmore D
Cancer Treat Rep; 1987 Feb; 71(2):119-25. PubMed ID: 3542208
[TBL] [Abstract][Full Text] [Related]
10. Summary of recent clinical experience in whole-body hyperthermia combined with chemotherapy.
Engelhardt R
Recent Results Cancer Res; 1988; 107():200-4. PubMed ID: 2836919
[No Abstract] [Full Text] [Related]
11. Clinical studies of autologous bone marrow transplantation in Hodgkin's disease.
Phillips GL; Reece DE
Clin Haematol; 1986 Feb; 15(1):151-66. PubMed ID: 3516487
[TBL] [Abstract][Full Text] [Related]
12. Alternating chemotherapy with cyclophosphamide, doxorubicin, vincristine and cisplatin, etoposide followed by prophylactic cranial and thoracic irradiation for small cell lung cancer (SCLC): long-term results.
Ardizzoni A; Fusco V; Pennucci C; Baldini E; Orsatti M; Vitale V; Bonavia M; Baracco F; Mereu C; Rosso R
Anticancer Res; 1991; 11(2):681-4. PubMed ID: 1648333
[TBL] [Abstract][Full Text] [Related]
13. [Dose-effect of chemotherapy in bronchial small-cell cancer].
de Crevoisier R; le Cesne A; le Chevalier T
Rev Mal Respir; 1997 Sep; 14(4):269-75. PubMed ID: 9411610
[TBL] [Abstract][Full Text] [Related]
14. Cyclocreatine in cancer chemotherapy.
Teicher BA; Menon K; Northey D; Liu J; Kufe DW; Kaddurah-Daouk R
Cancer Chemother Pharmacol; 1995; 35(5):411-6. PubMed ID: 7850923
[TBL] [Abstract][Full Text] [Related]
15. High-dose chemotherapy with bone marrow support for solid tumors.
Antman K; Eder JP; Frei E
Important Adv Oncol; 1987; ():221-35. PubMed ID: 2841230
[No Abstract] [Full Text] [Related]
16. Cyclophosphamide, vincristine, cisplatin, VP-16 and radiation therapy in extensive small-cell lung cancer. A Southwest Oncology Group Study.
Collins C; Higano CS; Livingston RB; Griffin BR; Keppen MD; Miller TP
Cancer Chemother Pharmacol; 1989; 24(2):128-32. PubMed ID: 2543513
[TBL] [Abstract][Full Text] [Related]
17. Alternating chemotherapy and thoracic radiotherapy with concurrent cisplatin-etoposide for limited-stage small-cell carcinoma of the lung.
Murray N; Shah A; Brown E; Kostashuk E; Laukkanen E; Goldie J; Band P; Van den Hoek J; Murphy K; Sparling T
Semin Oncol; 1986 Sep; 13(3 Suppl 3):24-30. PubMed ID: 3020695
[TBL] [Abstract][Full Text] [Related]
18. Etoposide-cisplatin and thoracic radiation therapy salvage of incomplete responders to a noncisplatin induction regimen for limited and extensive small-cell carcinoma of the lung.
Shaw EG; Frytak S; Eagan RT; Richardson RL; Creagan ET; Jett JR; Foote RL; Su JQ; Schaid DJ; Lee RE
Am J Clin Oncol; 1996 Apr; 19(2):154-8. PubMed ID: 8610640
[TBL] [Abstract][Full Text] [Related]
19. The role of autologous bone marrow transplantation in various malignancies.
Dicke KA; Jagannath S; Spitzer G; Poynton C; Zander A; Vellekoop L; Reading CL; Jehn UW; Tindle S
Semin Hematol; 1984 Apr; 21(2):109-22. PubMed ID: 6330904
[No Abstract] [Full Text] [Related]
20. Pilot study of cyclophosphamide-doxorubicin-vincristine-cisplatin-etoposide hybrid chemotherapy in small cell lung cancer.
Ohnoshi T; Hiraki S; Ueoka H; Kiura K; Kamei H; Horiguchi T; Kodani T; Maeda T; Tabata M; Shibayama T
Cancer; 1993 Sep; 72(5):1597-601. PubMed ID: 8394202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
